That pesky prostate and the saw palmetto
Powers, J.E.
South Dakota Journal of Medicine 50(12): 453-454
1997
ISSN/ISBN: 0038-3317 PMID: 9433100 Document Number: 476529
This installment in the series complements Molecular Medicine X to complete the discussion of "non-traditional inheritance"-concepts recently recognized or expanded to explain clinical observations that do not fall neatly under mendelian laws. These include mosaicism, genomic imprinting, uniparental disomy, triplet repeats, microdeletions and contiguous gene syndromes, and mitochondrial disorders.
Document emailed within 1 workday
Related Documents
Zhan, X.-x.; Shang, X.-j.; Huang, Y.-f. 2015: Application of saw palmetto fruit extract in the treatment of prostate diseases Zhonghua Nan Ke Xue 21(9): 841-846Villanueva, S.; González, J. 2009: Coagulopathy induced by saw palmetto: a case report Boletin de la Asociacion Medica de Puerto Rico 101(3): 48-50
Romppanen, J.; Haapalainen, T.; Punnonen, K.; Penttilä, I. 2002: Serum sialic acid and prostate-specific antigen in differential diagnosis of benign prostate hyperplasia and prostate cancer Anticancer Research 22(1a): 415-420
Murray, N.P.; Aedo, S.óc.; Reyes, E.; Fuentealba, C.; Jacob, O. 2019: Primary circulating prostate cells, age and prostatic volumen predict the presence of prostate cancer in men with indication of a second prostate biopsy Archivos Espanoles de Urologia 72(1): 16-24
Bauer, H.W.; Casarosa, C.; Cosci, M.; Fratta, M.; Blessmann, G. 1999: Saw palmetto fruit extract for treatment of benign prostatic hyperplasia. Results of a placebo-controlled double-blind study MMW Fortschritte der Medizin 141(25): 62
Sorenson, W.R.; Sullivan, D. 2006: Determination of campesterol, stigmasterol, and beta-sitosterol in saw palmetto raw materials and dietary supplements by gas chromatography: single-laboratory validation Journal - Association of Official Analytical Chemists 89(1): 22-34
Kumar, N.; Vasudeva, P.; Kumar, A.; Singh, H.; Sinha, A. 2015: A prospective comparative study of channel photoselective vaporization of prostate vs. channel transurethral resection of prostate in patients with advanced carcinoma prostate Minerva Urologica e Nefrologica 2015
Kumar, N.; Vasudeva, P.; Kumar, A.; Singh, H.; Sinha, A. 2016: A prospective comparative study of channel photoselective vaporization of the prostate vs. channel transurethral resection of the prostate in patients with advanced prostate carcinoma Minerva Urologica e Nefrologica 68(4): 330-336
Anderson, M.L. 2005: A preliminary investigation of the enzymatic inhibition of 5alpha-reduction and growth of prostatic carcinoma cell line LNCap-FGC by natural astaxanthin and Saw Palmetto lipid extract in vitro Journal of Herbal PharmacoTherapy 5(1): 17-26
Wadström, J.; Huber, P.R.; Scholer, A.; Rutishauser, G. 1984: Effect of prostate massage on the levels of prostate acid phosphatase in the serum and urine Helvetica Chirurgica Acta 51(3-4): 437-440
Bostwick, D.G. 1994: Prostate-specific antigen. Current role in diagnostic pathology of prostate cancer American Journal of Clinical Pathology 102(4 Suppl 1): S31-S37
Qiu, M-xing.; Wang, D.; Wu, H-min.; Xiong, G-bing.; Chen, Z-xiang. 2007: Dissection of prostate coalesce in treatment of benign prostate hypertrophy with relatively small volume Zhonghua Yi Xue Za Zhi 87(26): 1852-1853
Wang, W.; Mo, Z.-N. 2010: Advances in prostate-specific membrane antigen targeted therapies for prostate cancer Zhonghua Nan Ke Xue 16(6): 547-551
Fornara, P.; Sturm, W.; Fabricius, P.G.; Schmiedt, E. 1987: Clinical relevance of radioimmunologic determination of prostate specific antigen in prostate cancer Der Urologe. Ausg. a 26(3): 158-161
Lieberman, S. 1999: Can percent free prostate-specific antigen reduce the need for prostate biopsy? Effective Clinical Practice: Ecp 2(6): 266-271
Semjonow, A.; Hertle, L. 1995: Can the tumor stage of prostate carcinoma be determined with the aid of prostate-specific antigen? Der Urologe. Ausg. a 34(4): 290-296
Obralic, N.; Kulovac, B.; Aganovic, D.; Junuzovic, D. 2009: Values of prostate specific antigen in patients with operable prostate carcinoma Medicinski Arhiv 63(1): 34-37
Kelly, W.K.; Slovin, S.; Scher, H.I. 1996: Clinical use of posttherapy prostate-specific antigen changes in advanced prostate cancer Seminars in Oncology 23(6 Suppl 14: 8-14
Schäfer, U.; Micke, O.; Hampel, G.; Brandt, B.; Bovenschulte, A.; Semjonow, A.; Willich, N. 1997: The use of prostate-specific antigen (PSA) for the monitoring of radiation therapy in prostate cancer Anticancer Research 17(4b): 2983-2986
Serdar, M.A.; Oguz, O.; Olgun, A.; Seçkin, B.; Ilgan, S.; Hasimi, A.; Salih, M.; Peker, F.; Kutluay, T. 2002: Diagnostic approach to prostate cancer using total prostate specific antigen-based parameters together Annals of Clinical and Laboratory Science 32(1): 22-30